SCHEMBL9708208

SCHEMBL9708208

CCCCCc1nc2c(c(=O)[nH]c(=O)n2CCc2ccccc2)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1

nearest known ligand 0.49

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.49
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
KDM4E B2RXH2 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
HTT P42858 1/20 0.49
AGTR1 P30556 7/20 0.46
AGTR2 P50052 7/20 0.46
USP2 O75604 1/20 0.46
RAB9A P51151 1/20 0.46
TPH1 P17752 2/20 0.46
TPH2 Q8IWU9 2/20 0.46
HPGD P15428 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9708270 0.98 MEN1 (0.49) ALDH1A1MEN1KMT2AKDM4ESMN1; SMN2
SCHEMBL9708233 0.95 TPH1 (0.49) ALDH1A1MEN1KMT2AKDM4ESMN1; SMN2
SCHEMBL9708930 0.94 MEN1 (0.50) ALDH1A1MEN1KMT2AKDM4ESMN1; SMN2
SCHEMBL9707286 0.93 AGTR1 (0.50) ALDH1A1MEN1KMT2AKDM4ESMN1; SMN2
SCHEMBL9707289 0.93 MEN1 (0.52) MEN1KMT2AAGTR1AGTR2TPH1
SCHEMBL9708384 0.92 MEN1 (0.48) ALDH1A1MEN1KMT2AKDM4ESMN1; SMN2
SCHEMBL9708458 0.92 KDM4E (0.46) ALDH1A1MEN1KMT2AKDM4ESMN1; SMN2
SCHEMBL9707996 0.91 USP2 (0.52) ALDH1A1MEN1KMT2AAGTR1AGTR2
SCHEMBL9708426 0.90 MEN1 (0.53) MEN1KMT2AAGTR1AGTR2TPH1
SCHEMBL9707363 0.90 AGTR1 (0.46) MEN1KMT2AAGTR1AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1992007852-A1 BIPHENYLALKYL XANTHINE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1992-05-14 WO disclosed